2026 Drug Cost Guide: Keytruda, Wegovy, Mounjaro, Zepbound, Opdivo & Imfinzi Prices

Updated U.S. drug cost data (Keytruda, Wegovy, Mounjaro, Zepbound) — Insurance, savings & 2026 trends.

Showing 13 - 18 of 18 drug pricing articles
How Much Does Semaglutide Cost in the US Without Insurance (2025) - 2026 Drug Cost Analysis

How Much Does Semaglutide Cost in the US Without Insurance (2025)

75 views

In 2025, the cost of semaglutide (Ozempic, Wegovy, Rybelsus) in the United States remains one of the biggest challenges for patients without insurance. On average, the monthly out-of-pocket price ranges between $1,000 and $1,400, depending on dosage and brand. Even though semaglutide is highly effective for type 2 diabetes and weight loss, its high retail cost makes it inaccessible for many people. However, patients can lower their expenses through manufacturer savings programs, GoodRx coupons, and pharmacy discount cards, which may reduce the Wegovy cash price or Ozempic monthly cost to as little as $499. Alternatives such as Mounjaro (tirzepatide) or compounded semaglutide also exist, but safety and availability should always be considered. This guide explores real patient costs, discount programs, insurance coverage updates, and the future of GLP-1 drug pricing, helping you understand exactly what to expect if you’re paying for semaglutide out of pocket in 2025.

Keytruda Price Per Dose vs. Per Year — Full Breakdown (2025) - 2026 Drug Cost Analysis

Keytruda Price Per Dose vs. Per Year — Full Breakdown (2025)

430 views

Keytruda (pembrolizumab) is one of the most widely prescribed immunotherapy drugs for cancer, but its cost continues to be a major concern for patients in 2025. On average, a single 200 mg intravenous dose is estimated at around $11,700 under Medicare ASP pricing, while a 6-week 400 mg dose carries a published list price of $23,590. Depending on the treatment plan, annual costs can exceed $200,000 per patient. In 2025, Merck also introduced a new subcutaneous formulation (Keytruda QLEX), which offers shorter administration times but could bring different pricing models compared to IV dosing. Insurance coverage, Medicare billing rules, and patient assistance programs remain critical factors in determining real out-of-pocket costs.

Opdivo Cost per Month: Nivolumab Price & Insurance Coverage in the USA (2025) - 2026 Drug Cost Analysis

Opdivo Cost per Month: Nivolumab Price & Insurance Coverage in the USA (2025)

128 views

Opdivo (nivolumab) is one of the most widely used immunotherapy drugs in the United States, but its cost can be overwhelming for many cancer patients. In 2025, the monthly price of Opdivo ranges from $15,000 to over $20,000 before insurance, depending on dosage and treatment schedule. The good news is that Medicare, private insurance, and financial assistance programs can reduce these expenses significantly, sometimes lowering patient out-of-pocket costs to only a few hundred dollars per month. This guide explains the real cost of Opdivo per month, how insurance coverage works, and what assistance options are available to help patients manage treatment expenses.

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025? - 2026 Drug Cost Analysis

Opdivo Cost in the USA: How Much Does Nivolumab Really Cost in 2025?

229 views

In 2025, the cost of Opdivo (Nivolumab) in the United States continues to be a major concern for cancer patients and families. With monthly expenses ranging from $12,000 to $26,000 without insurance, many wonder how they can afford this life-saving immunotherapy. This article explains the true price of Opdivo in 2025, how much insurance covers, available patient assistance programs, and how Opdivo compares to other cancer treatments like Keytruda and Yervoy. You’ll also find updated FAQs with trusted links to help patients make informed financial and medical decisions.

How Much Does Keytruda Cost Per Month? - 2026 Drug Cost Analysis

How Much Does Keytruda Cost Per Month?

388 views

Keytruda (pembrolizumab) has transformed cancer treatment, but its price tag remains one of the highest in oncology. In 2025, the average monthly cost of Keytruda in the United States is estimated at $15,000 to $16,000, depending on the dosing schedule. While list prices are staggering, most patients do not pay this full amount thanks to insurance coverage, Medicare benefits, and financial assistance programs. Still, questions like “How much does Keytruda cost per month?” and “Why is Keytruda so expensive?” are critical for patients, caregivers, and policymakers navigating the realities of modern cancer care.

Keytruda Cost in the USA: How Much Does Pembrolizumab Really Cost in 2025? - 2026 Drug Cost Analysis

Keytruda Cost in the USA: How Much Does Pembrolizumab Really Cost in 2025?

907 views

Keytruda (pembrolizumab) is one of the most widely used immunotherapy drugs for treating different types of cancer, including lung cancer, melanoma, and head and neck cancers. In the United States, the cost of Keytruda can be a major concern for patients and their families, as it is often priced at several thousand dollars per infusion. This article explores the average cost of Keytruda in the USA, insurance coverage options, financial assistance programs, and helpful resources for patients seeking more affordable access.

Drug Price FAQs: Keytruda, Wegovy, Mounjaro & More

The average cost of Keytruda without insurance in 2026 is around $10,000 to $13,000 per dose. With insurance, out-of-pocket expenses can be as low as $100 depending on the coverage.

Experts expect Zepbound’s price to drop by 10–15% in 2026 as competition and insurance coverage expand. Savings cards and manufacturer programs are also expected to continue.

Wegovy costs between $25 and $150 per month with most insurance plans in the U.S. Without insurance, the price is around $1,350 monthly.

Top Drug Comparisons 2026: Keytruda, Mounjaro, Wegovy & Zepbound

Keytruda vs Opdivo

Compare the 2026 cost, effectiveness, and insurance coverage of both cancer treatments.

Compare Now

Wegovy vs Zepbound

Find out which weight-loss drug offers the best value and results in 2026.

Read Comparison

Mounjaro Savings 2026

Learn how to get the best savings and discounts for Mounjaro through insurance and cards.

See Savings